The global metabolomics market is entering a transformative decade marked by accelerated research, widespread adoption of precision medicine, and rapid advancements in analytical technologies. Valued at US$ 2.7 billion in 2023, the market is projected to rise at a CAGR of 12.3% from 2024 to 2034, ultimately surpassing US$ 9.5 billion by the end of 2034. This impressive...